Assyro AI

FDA Orange Book · active-ingredient family

Trifluoperazine hydrochloride

Trifluoperazine hydrochloride is approved as 1 brand and 20 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:STELAZINE · NDA 011552

1

Brand (NDA)

20

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · concentrate, injectable, tablet

ProductApplicantApplicationTEApproved
STELAZINERLD×6GLAXOSMITHKLINENDA 011552Approved Prior to Jan 1, 1982

Generic (ANDA) products (20)

ProductApplicantApplicationTEApproved
TRIFLUOPERAZINE HYDROCHLORIDE×4MYLANANDA 040209ABJul 07, 1997
TRIFLUOPERAZINE HYDROCHLORIDE×4POM PHARMAANDA 040153Oct 25, 1996
TRIFLUOPERAZINE HYDROCHLORIDEWATSON LABSANDA 085975Jun 23, 1988
TRIFLUOPERAZINE HYDROCHLORIDEWATSON LABSANDA 085976Jun 23, 1988
TRIFLUOPERAZINE HYDROCHLORIDEWATSON LABSANDA 085973Jun 23, 1988
TRIFLUOPERAZINE HYDROCHLORIDEWATSON LABSANDA 088710Jun 23, 1988
TRIFLUOPERAZINE HYDROCHLORIDEDURAMED PHARMS BARRANDA 088967Apr 23, 1985
TRIFLUOPERAZINE HYDROCHLORIDEDURAMED PHARMS BARRANDA 088968Apr 23, 1985
TRIFLUOPERAZINE HYDROCHLORIDEDURAMED PHARMS BARRANDA 088969Apr 23, 1985
TRIFLUOPERAZINE HYDROCHLORIDEDURAMED PHARMS BARRANDA 088970Apr 23, 1985
TRIFLUOPERAZINE HYDROCHLORIDEWOCKHARDTANDA 088143Jul 26, 1983
TRIFLUOPERAZINE HYDROCHLORIDEIVAX PHARMSANDA 087612Nov 19, 1982
TRIFLUOPERAZINE HYDROCHLORIDEIVAX PHARMSANDA 087613Nov 19, 1982
TRIFLUOPERAZINE HYDROCHLORIDEIVAX PHARMSANDA 087328Nov 19, 1982
TRIFLUOPERAZINE HYDROCHLORIDEIVAX PHARMSANDA 087614Nov 19, 1982
TRIFLUOPERAZINE HYDROCHLORIDECHARTWELL RXANDA 085787Apr 15, 1982
TRIFLUOPERAZINE HYDROCHLORIDESANDOZANDA 085785ABApproved Prior to Jan 1, 1982
TRIFLUOPERAZINE HYDROCHLORIDESANDOZANDA 085786ABApproved Prior to Jan 1, 1982
TRIFLUOPERAZINE HYDROCHLORIDESANDOZANDA 085789ABApproved Prior to Jan 1, 1982
TRIFLUOPERAZINE HYDROCHLORIDESANDOZANDA 085788ABApproved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Trifluoperazine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.